Contact
searchSearch
HMP Global

Diabetes Topic Center

Featured Article

News
Complex Medication Regimens Associated With Poorer Type 2 Diabetes Outcomes
01/03/2023
In addition to determining the link between regimen complexity and A1c, researchers recommended strategies for improving outcomes in underserved populations.
In addition to determining the link between regimen complexity and A1c, researchers recommended strategies for improving outcomes in underserved populations.
In addition to determining the...
01/03/2023
Pharmacy Learning Network
From Pharmacy Learning Network
Headshot of Stephanie Ostling Mason, Glytec, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Improving Glycemic Management for Better Outcomes, Cost Savings
12/07/2022
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD,...
12/07/2022
Pharmacy Learning Network
From Pharmacy Learning Network
News
Pharmacist-led Telehealth Diabetes Management Improved Rural Veterans’ Glycemic Control During Pandemic
11/21/2022
Diabetes management via telehealth presented an opportunity for pharmacists to reduce health care disparities by reaching veterans living in rural areas, researchers said.
Diabetes management via telehealth presented an opportunity for pharmacists to reduce health care disparities by reaching veterans living in rural areas, researchers said.
Diabetes management via...
11/21/2022
Veterans Health Today
From Veterans Health Today
Conference Coverage
Predicting Diabetes Medication Adherence With Pharmacy Claims, Public Data
10/11/2022
Researchers at AMCP Nexus 2022 combined publicly available and pharmacy claims data to understand how patients' social determinants of health affected care access and treatment adherence.
Researchers at AMCP Nexus 2022 combined publicly available and pharmacy claims data to understand how patients' social determinants of health affected care access and treatment adherence.
Researchers at AMCP Nexus 2022...
10/11/2022
Pharmacy Learning Network
From Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
New Data Emerges for Managing Type 2 Diabetes
10/06/2022
Dr Jennings explores research comparing the efficacy of several SGLT2 inhibitors as second-line therapy options for patients with type 2 diabetes who have been treated with metformin.
Dr Jennings explores research comparing the efficacy of several SGLT2 inhibitors as second-line therapy options for patients with type 2 diabetes who have been treated with metformin.
Dr Jennings explores research...
10/06/2022
Pharmacy Learning Network
From Pharmacy Learning Network
Save Those Kidney Beans: Nephro-Protective Effects of SGLT2 Inhibitors
Commentary
Save Those Kidney Beans: Nephro-Protective Effects of SGLT2 Inhibitors
05/05/2021
In this week’s issue of Talking Therapeutics, Dr Jennings explores a new drug approval and what it means for patients with chronic kidney disease.
In this week’s issue of Talking Therapeutics, Dr Jennings explores a new drug approval and what it means for patients with chronic kidney disease.
In this week’s issue of Talking...
05/05/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Predicting the Need for SGLT2 Inhibitors for Future Heart Failure
Commentary
Predicting the Need for SGLT2 Inhibitors for Future Heart Failure
02/23/2021
“The SGLT2i are an expensive group of drugs in comparison to other goal-directed medical therapies for HfrEF, says Mark Munger, PharmD. “Perhaps this data might assist in formulary decisions and oversight use of these medications.”
“The SGLT2i are an expensive group of drugs in comparison to other goal-directed medical therapies for HfrEF, says Mark Munger, PharmD. “Perhaps this data might assist in formulary decisions and oversight use of these medications.”
“The SGLT2i are an expensive...
02/23/2021
Pharmacy Learning Network
From Pharmacy Learning Network
Commentary
The Expanding Clinical Benefits Linked With Metformin Use: New Study Provides More Data Suggesting Metformin is Associated With Reduced COVID-19 Mortality Rates
02/02/2021
“Research indicates that metformin may exert the various clinical effects via different signaling pathways; however, the precise mechanisms have not yet been determined and research is ongoing,” says Yvette C. Terrie, BS Pharm, RPh,...
“Research indicates that metformin may exert the various clinical effects via different signaling pathways; however, the precise mechanisms have not yet been determined and research is ongoing,” says Yvette C. Terrie, BS Pharm, RPh,...
“Research indicates that...
02/02/2021
Pharmacy Learning Network
From Pharmacy Learning Network
News
VA Diabetes Risk Cohort Provides Largest Pool of US Adults Without Diabetes at Baseline
12/10/2020
“This cohort also establishes a baseline against which to assess the impact of national or regional strategies to prevent diabetes in veterans,” the authors wrote. “It also provides an analytic cohort to examine the dynamic relationship...
“This cohort also establishes a baseline against which to assess the impact of national or regional strategies to prevent diabetes in veterans,” the authors wrote. “It also provides an analytic cohort to examine the dynamic relationship...
“This cohort also establishes a...
12/10/2020
Veterans Health Today
From Veterans Health Today
News
Continuous Diffusion of Oxygen Therapy Cost-Effective for Advanced Diabetic Foot Ulcers
11/19/2020
The average 5-year cost per patient receiving continuous delivery of oxygen (CDO) in the base case was an estimated $78,500 compared with $83,300 for negative pressure wound therapy, resulting in a savings of $4800 with CDO.
The average 5-year cost per patient receiving continuous delivery of oxygen (CDO) in the base case was an estimated $78,500 compared with $83,300 for negative pressure wound therapy, resulting in a savings of $4800 with CDO.
The average 5-year cost per...
11/19/2020
First Report Managed Care
From First Report Managed Care
News
Study Finds Higher 5-Year Costs With Semaglutide Instead of Sitagliptin for Type 2 Diabetes
11/12/2020
"Use of oral semaglutide 14 mg in patients currently receiving sitagliptin 100 mg substantially increases the budget impact for patients with T2DM whose blood glucose level is not controlled with metformin over a 5-year time horizon for US...
"Use of oral semaglutide 14 mg in patients currently receiving sitagliptin 100 mg substantially increases the budget impact for patients with T2DM whose blood glucose level is not controlled with metformin over a 5-year time horizon for US...
"Use of oral semaglutide 14 mg...
11/12/2020
First Report Managed Care
From First Report Managed Care

Newsfeed

News
Complex Medication Regimens Associated With Poorer Type 2 Diabetes Outcomes
01/03/2023
In addition to determining the link between regimen complexity and A1c, researchers recommended strategies for improving outcomes in underserved populations.
In addition to determining the link between regimen complexity and A1c, researchers recommended strategies for improving outcomes in underserved populations.
In addition to determining the...
01/03/2023
Pharmacy Learning Network
News
Pharmacist-led Telehealth Diabetes Management Improved Rural Veterans’ Glycemic Control During Pandemic
11/21/2022
Diabetes management via telehealth presented an opportunity for pharmacists to reduce health care disparities by reaching veterans living in rural areas, researchers said.
Diabetes management via telehealth presented an opportunity for pharmacists to reduce health care disparities by reaching veterans living in rural areas, researchers said.
Diabetes management via...
11/21/2022
Veterans Health Today
News
VA Diabetes Risk Cohort Provides Largest Pool of US Adults Without Diabetes at Baseline
12/10/2020
“This cohort also establishes a baseline against which to assess the impact of national or regional strategies to prevent diabetes in veterans,” the authors wrote. “It also provides an analytic cohort to examine the dynamic relationship...
“This cohort also establishes a baseline against which to assess the impact of national or regional strategies to prevent diabetes in veterans,” the authors wrote. “It also provides an analytic cohort to examine the dynamic relationship...
“This cohort also establishes a...
12/10/2020
Veterans Health Today
News
Continuous Diffusion of Oxygen Therapy Cost-Effective for Advanced Diabetic Foot Ulcers
11/19/2020
The average 5-year cost per patient receiving continuous delivery of oxygen (CDO) in the base case was an estimated $78,500 compared with $83,300 for negative pressure wound therapy, resulting in a savings of $4800 with CDO.
The average 5-year cost per patient receiving continuous delivery of oxygen (CDO) in the base case was an estimated $78,500 compared with $83,300 for negative pressure wound therapy, resulting in a savings of $4800 with CDO.
The average 5-year cost per...
11/19/2020
First Report Managed Care
News
Study Finds Higher 5-Year Costs With Semaglutide Instead of Sitagliptin for Type 2 Diabetes
11/12/2020
"Use of oral semaglutide 14 mg in patients currently receiving sitagliptin 100 mg substantially increases the budget impact for patients with T2DM whose blood glucose level is not controlled with metformin over a 5-year time horizon for US...
"Use of oral semaglutide 14 mg in patients currently receiving sitagliptin 100 mg substantially increases the budget impact for patients with T2DM whose blood glucose level is not controlled with metformin over a 5-year time horizon for US...
"Use of oral semaglutide 14 mg...
11/12/2020
First Report Managed Care
News
Diabetes Increases Readmission Risk After Elective Total Joint Arthroplasty
10/31/2020
Medicare beneficiaries undergoing elective total knee arthroplasty or total hip arthroplasty have increased odds of complications and hospital readmissions if they have diabetes, according to a study published online in The Journal of Bone &...
Medicare beneficiaries undergoing elective total knee arthroplasty or total hip arthroplasty have increased odds of complications and hospital readmissions if they have diabetes, according to a study published online in The Journal of Bone &...
Medicare beneficiaries...
10/31/2020
First Report Managed Care
News
SGLT2 Inhibitors Estimated to Be Cost-Effective for Type 2 Diabetes
10/15/2020
“The findings highlight the need to take into account cost savings from reducing common, morbid, and preventable type 2 diabetes mellitus complications when considering the cost of diabetes medications,” researchers wrote.
“The findings highlight the need to take into account cost savings from reducing common, morbid, and preventable type 2 diabetes mellitus complications when considering the cost of diabetes medications,” researchers wrote.
“The findings highlight the need...
10/15/2020
First Report Managed Care
News
Physician-Pharmacist Collaboration Improves Diabetes Outcomes, Reduces Costs
10/08/2020
“The significant cost savings associated with the reduction in all-cause emergency department visits and hospitalizations as well as the improvement in diabetes outcomes found in this study could be utilized to justify the addition of a...
“The significant cost savings associated with the reduction in all-cause emergency department visits and hospitalizations as well as the improvement in diabetes outcomes found in this study could be utilized to justify the addition of a...
“The significant cost savings...
10/08/2020
First Report Managed Care
News
Evidence Gap in Pay-for-Performance Plan Assessment Could Worsen Gender Inequalities
10/01/2020
Researchers conducted a gender-based analysis of 39 studies of eight pay-for-performance interventions spanning seven countries and focused on pay-for-performance plans for patients with diabetes.
Researchers conducted a gender-based analysis of 39 studies of eight pay-for-performance interventions spanning seven countries and focused on pay-for-performance plans for patients with diabetes.
Researchers conducted a...
10/01/2020
First Report Managed Care
News
Including Dementia in Economic Analyses of Diabetes Prevention Program Has Little Effect
09/29/2020
Adding dementia to an existing economic model evaluating lifestyle interventions to prevent diabetes and cardiovascular disease was feasible but did not affect policy recommendations or economic outcomes, according to a study
Adding dementia to an existing economic model evaluating lifestyle interventions to prevent diabetes and cardiovascular disease was feasible but did not affect policy recommendations or economic outcomes, according to a study
Adding dementia to an existing...
09/29/2020
First Report Managed Care
News
Increased Scrutiny of Prior Authorization: Are Payers Fully to Blame, and Can AI Improve the Process?
04/05/2024
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior authorization, highlighted by media reports and government actions, prompts debate over payer responsibility while exploring the potential for AI to enhance the process.
The increased scrutiny of prior...
04/05/2024
First Report Managed Care
News
PhRMA Maps Provide State-by-State Look at 340B Drug Program
04/05/2024
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made available by the Pharmaceutical Research and Manufacturers of America (PhRMA), a drugmaker advocacy group, shares state-specific data on the 340B Drug Pricing Program. The federal program, initially created over 30...
An interactive map made...
04/05/2024
First Report Managed Care
News
FTC and HHS Launch Joint Inquiry into Generic Drug Shortages: Seeking Public Input on GPOs and Wholesalers
02/16/2024
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on...
02/16/2024
First Report Managed Care
News
Medicare Drug Price Negotiations and Anticipated Ripple Effects
02/15/2024
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation Reduction Act has ushered in a new era of drug price regulation, giving the Centers for Medicare & Medicaid Services (CMS) the ability to negotiate directly with companies that make some of the costliest drugs...
The arrival of the Inflation...
02/15/2024
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
First Gene Therapy for Severe Hemophilia A Is Approved
06/29/2023
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a safety and effectiveness trial showed that the treatment improved participants’ annualized bleeding rate after 3 years.
This approval comes after a...
06/29/2023
Population Health
News
Low Rate of Social Determinants of Health Z Codes in Adults With Hypertension
06/26/2023
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the presence and use of ICD-10-CM social determinants of health (SDOH)-related Z codes among adults with hypertension and found differences in documentation and medical expenditures.
Researchers examined the...
06/26/2023
First Report Managed Care
News
CDC Data Shows Link Between High Costs and Prescription Nonadherence in Adults
06/21/2023
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence among adults was associated with costs, gender, disability status, insurance coverage, and other characteristics.
In 2021, medication nonadherence...
06/21/2023
First Report Managed Care
News
Blood Pressure Injections Recalled
05/26/2023
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products containing phenylephrine and norepinephrine were recalled due to a lack of sterility assurance.
Several thousand products...
05/26/2023
Pharmacy Learning Network
News
Astral SteriTech Recalls 5 Injections Manufactured for 4 US Clients
05/26/2023
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II by the US Food and Drug Administration, impact a variety of antibiotic injections.
The recalls, designated Class II...
05/26/2023
Pharmacy Learning Network

Insights

Headshot of Stephanie Ostling Mason, Glytec, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Improving Glycemic Management for Better Outcomes, Cost Savings
12/07/2022
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD,...
12/07/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
New Data Emerges for Managing Type 2 Diabetes
10/06/2022
Dr Jennings explores research comparing the efficacy of several SGLT2 inhibitors as second-line therapy options for patients with type 2 diabetes who have been treated with metformin.
Dr Jennings explores research comparing the efficacy of several SGLT2 inhibitors as second-line therapy options for patients with type 2 diabetes who have been treated with metformin.
Dr Jennings explores research...
10/06/2022
Pharmacy Learning Network
Save Those Kidney Beans: Nephro-Protective Effects of SGLT2 Inhibitors
Commentary
Save Those Kidney Beans: Nephro-Protective Effects of SGLT2 Inhibitors
05/05/2021
In this week’s issue of Talking Therapeutics, Dr Jennings explores a new drug approval and what it means for patients with chronic kidney disease.
In this week’s issue of Talking Therapeutics, Dr Jennings explores a new drug approval and what it means for patients with chronic kidney disease.
In this week’s issue of Talking...
05/05/2021
Pharmacy Learning Network
Predicting the Need for SGLT2 Inhibitors for Future Heart Failure
Commentary
Predicting the Need for SGLT2 Inhibitors for Future Heart Failure
02/23/2021
“The SGLT2i are an expensive group of drugs in comparison to other goal-directed medical therapies for HfrEF, says Mark Munger, PharmD. “Perhaps this data might assist in formulary decisions and oversight use of these medications.”
“The SGLT2i are an expensive group of drugs in comparison to other goal-directed medical therapies for HfrEF, says Mark Munger, PharmD. “Perhaps this data might assist in formulary decisions and oversight use of these medications.”
“The SGLT2i are an expensive...
02/23/2021
Pharmacy Learning Network
Commentary
The Expanding Clinical Benefits Linked With Metformin Use: New Study Provides More Data Suggesting Metformin is Associated With Reduced COVID-19 Mortality Rates
02/02/2021
“Research indicates that metformin may exert the various clinical effects via different signaling pathways; however, the precise mechanisms have not yet been determined and research is ongoing,” says Yvette C. Terrie, BS Pharm, RPh,...
“Research indicates that metformin may exert the various clinical effects via different signaling pathways; however, the precise mechanisms have not yet been determined and research is ongoing,” says Yvette C. Terrie, BS Pharm, RPh,...
“Research indicates that...
02/02/2021
Pharmacy Learning Network
Commentary
Implementing Patient Education Strategies to Help Patients in Reducing or Preventing the Incidence of Prediabetes, Type 2 Diabetes
08/04/2020
As frontline health care providers, pharmacists are in a pivotal position to act as patient identifiers, patient educators and patient advocates especially for those at risk for or with diabetes.
As frontline health care providers, pharmacists are in a pivotal position to act as patient identifiers, patient educators and patient advocates especially for those at risk for or with diabetes.
As frontline health care...
08/04/2020
Pharmacy Learning Network
Examining a Treatment Option for Veterans With Diabetes, Foot Ulcers
Podcasts
Examining a Treatment Option for Veterans With Diabetes, Foot Ulcers
06/23/2020
Bob Maguire, BioLab Sciences, and Charles Pollak, Red One Medical, discuss their recent partnership and highlight a treatment option for veterans with diabetic foot ulcers, which impacts roughly 75,000 veterans.
Bob Maguire, BioLab Sciences, and Charles Pollak, Red One Medical, discuss their recent partnership and highlight a treatment option for veterans with diabetic foot ulcers, which impacts roughly 75,000 veterans.
Bob Maguire, BioLab Sciences,...
06/23/2020
Veterans Health Today
Barriers to Diabetes Treatment Linked With Increased Monthly Costs
Interview
Barriers to Diabetes Treatment Linked With Increased Monthly Costs
03/25/2020
Tayla Rose, PharmD, MEd, RPh, BCACP, CDE, assistant clinical professor in the Department of Pharmacy and Health Systems Sciences at Northeastern University School of Pharmacy, explains why providers should be mindful of the high cost of...
Tayla Rose, PharmD, MEd, RPh, BCACP, CDE, assistant clinical professor in the Department of Pharmacy and Health Systems Sciences at Northeastern University School of Pharmacy, explains why providers should be mindful of the high cost of...
Tayla Rose, PharmD, MEd, RPh,...
03/25/2020
Pharmacy Learning Network
Among Diabetes Patients, Cost Increases Linked With Guideline Non-Compliance
Interview
Among Diabetes Patients, Cost Increases Linked With Guideline Non-Compliance
03/10/2020
Swapnil Rajpathak, executive director cardiometabolic team, Center for Observational Real World Evidence, Merck & Co, Inc, discusses the importance of adherence to evidence-based care guidelines to improve health outcomes and reduce costs.
Swapnil Rajpathak, executive director cardiometabolic team, Center for Observational Real World Evidence, Merck & Co, Inc, discusses the importance of adherence to evidence-based care guidelines to improve health outcomes and reduce costs.
Swapnil Rajpathak, executive...
03/10/2020
First Report Managed Care
Limiting Major CVD Events With Metformin in Vets With Diabetes, Reduced Kidney Function
Interview
Limiting Major CVD Events With Metformin in Vets With Diabetes, Reduced Kidney Function
03/02/2020
Christianne Roumie, MD, MPH, associate professor of Internal Medicine and Pediatrics at Vanderbilt University Medical Center and the VA Tennessee Valley Healthcare System, discusses the benefits of the diabetes medication metformin on...
Christianne Roumie, MD, MPH, associate professor of Internal Medicine and Pediatrics at Vanderbilt University Medical Center and the VA Tennessee Valley Healthcare System, discusses the benefits of the diabetes medication metformin on...
Christianne Roumie, MD, MPH,...
03/02/2020
Veterans Health Today

What's Trending?

News
Featured Sessions at AHS 2018
11/14/2018
The Scottsdale Headache Symposium offers a variety of sessions and educational objectives to help attendees gain a better understanding of headache treatment.
The Scottsdale Headache Symposium offers a variety of sessions and educational objectives to help attendees gain a better understanding of headache treatment.
The Scottsdale Headache...
11/14/2018
First Report Managed Care
News
Merck Immunotherapy Appears Effective in Head and Neck Cancer
05/29/2015
A Merck drug that helps the immune system fight cancer was about twice as effective as the current standard therapy for patients with recurrent or advanced head and neck cancers, according to study data released on Friday.
A Merck drug that helps the immune system fight cancer was about twice as effective as the current standard therapy for patients with recurrent or advanced head and neck cancers, according to study data released on Friday.
A Merck drug that helps the...
05/29/2015
Pharmacy Learning Network
News
Survey: Fewer doctors taking freebies from drug companies
11/09/2010
11/09/2010
First Report Managed Care
News
Benefits of CD30 CAR-T Therapy for Multiply Relapsed Enteropathy-Associated T-Cell Lymphoma
12/10/2020
In a recent case study, CAR-T therapy targeting the CD30 molecule promoted a durable remission in a patient with multiply relapsed enteropathy-associated T-cell lymphoma after previous allogeneic stem cell transplantation.
In a recent case study, CAR-T therapy targeting the CD30 molecule promoted a durable remission in a patient with multiply relapsed enteropathy-associated T-cell lymphoma after previous allogeneic stem cell transplantation.
In a recent case study, CAR-T...
12/10/2020
First Report Managed Care
News
US Pharma Prices Increase by 9.8% in Past Year
07/18/2016
More than two-thirds of the 20 largest pharmaceutical companies, including Pfizer, Biogen, Gilead Sciences, Amgen, and AbbVie, have boosted their sales in the first quarter of 2016 by increasing prices on their biggest products.
More than two-thirds of the 20 largest pharmaceutical companies, including Pfizer, Biogen, Gilead Sciences, Amgen, and AbbVie, have boosted their sales in the first quarter of 2016 by increasing prices on their biggest products.
More than two-thirds of the 20...
07/18/2016
First Report Managed Care

Stay Informed—Sign up today!

Population Health Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use